AzTrials
AzTrials

Shift Work Sleep DisorderSAILNCT06809335

A Pilot of a Personalized Circadian mHealth to Improve Sleep in Night Shift Workers

A study testing Personalized circadian mHealth in people with Shift Work Sleep Disorder, run by Henry Ford Health System at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this project is to establish the evidence base for equitable accessibility and implementation of the precision sleep medicine mobile application, SHIFT. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Shift Work Sleep Disorder
What is being tested?
Personalized circadian mHealth
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 siteUnited States
Study dates
23 Oct 2023to Jun 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Inadequate sleep duration (habitual sleep less than 7 hours during the day)
  • Willingness to download the SHIFT app and follow the lighting recommendations
  • Ability to follow a set sleep schedule of 7 hours in bed after the night shifts
  • Working at least 4 night shifts a month
  • Shifts that must begin between 18:00 and 02:00 and last 8 to 12 hours
  • Score of 8 or above on the Epworth Sleepiness scale and/or a score of 8 or above on the Insomnia Severity Index

Who cannot join

  • Other independent sleep disorders (e.g., obstructive sleep apnea, narcolepsy, etc.)
  • History of seizures or other significant neurological disorders
  • Bipolar disorder
  • Termination of shift schedule
  • Pregnancy
  • Current use of medications that impact sleep-wake functioning
  • Alcohol and substance use disorder

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Philip Cheng, PhD contact

248-344-7361

pcheng1@hfhs.org

Marleigh Treger, BS contact

248-344-8028

mtreger1@hfhs.org

United States1 site, 1 recruiting
  • Henry Ford Columbus Medical Center

    Novi, Michigan, 48377

    Philip Cheng, PhD, 248-344-7361, pcheng1@hfhs.org

    Marleigh Treger, BS, 248-344-8028, mtreger1@hfhs.org

    Recruiting

Other trials in United States

About this study

The goal of this project is to establish the evidence base for equitable accessibility and implementation of the precision sleep medicine mobile application, SHIFT.

Being tested
Personalized circadian mHealth
Medical subject headings
Sleep Disorders, Circadian Rhythm

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Personalized circadian mHealthOther

    Also called SHIFT

    SHIFT is a mobile application designed to improve sleep in night shift workers. The SHIFT mobile application is used to collect data from an Apple Watch to assess an individual shift worker's body-clock timing and make personalized recommendations of light exposure schedules that are designed to align the body-clock with the night shift work schedule.

Study groups in NCT06809335
Study groupRoleWhat they receive
SHIFT AppExperimentalParticipants in this condition will receive an access code to download the mobile application and conduct an orientation to SHIFT and the study procedures with a study team member. They will then enter four weeks of study directed use of SHIFT where they are trained on a daily procedure of opening SHIFT at the beginning of their day and planning their day in accordance with the app recommendations. App usage (4 times per week) will be incentivized with weekly bonuses added to study compensation. Following the four weeks of study-directed use, participants will continue with self-directed use. At four months, participants will then complete a booster session with two additional weeks of study-directed use, followed by self-directed use until the end of the study. The structure with the booster session has evidence for maintaining treatment gains and is also in alignment with the commercialization plan.
Receives: Other: Personalized circadian mHealth
Waitlist ControlNo interventionParticipants in this condition will only complete questionnaires for the initial eight months. Those who remain shift workers will have the option of receiving the SHIFT app and the option to complete follow-up surveys in the same manner as the SHIFT App condition.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Establish the effect of SHIFT on stakeholder-centered outcomes.

    Aim 1a. Measure the effect of SHIFT on work productivity and satisfaction compared to waitlist control using the Job Satisfaction Index. Effect will be tested using a mixed-effects linear regression model with participants as the random effect and Time, Condition, and the Time × Condition interaction term as the fixed effects.

    Aim 1b: Measure the effect of SHIFT on global health compared to waitlist control using the NIH PROMIS Global Health questionnaire. Effect will be tested using the same method as Aim 1a.

    Aim 1c. Measure the effect of SHIFT on turnover compared to waitlist control, measured at 8-month follow-up. Turnover will be operationalized as an individual who has either terminated the position they were in at baseline or is no longer engaged in shift work as operationalized in the study. Effect will be determined using a generalized mixed-effects regression with turnover as a dichotomous outcome.

    Measured: From enrollment to the 8 month point.

  2. Compare use experience and accuracy of SLEEP Android to the original iOS version.

    Aim 2a. Measure user experience of Android and iOS versions of SHIFT using the User Experience Questionnaire (UEQ). The following ranges of clinical indifference will be used: ± 3 points on the User Experience Questionnaire based on the bin size of 6 for each of the thresholds (bad, neutral, and good user experience).

    Aim 2b. Measure accuracy of predicted circadian misalignment (CM), sleep, and depression in Android and iOS versions. CM will be indexed with the outputs of the biomathematical model of the circadian system. Sleep will be measured using the Insomnia Severity Index and sleep diaries. Depression will be measured using the Quick Inventory of Depressive Symptomatology. The following ranges of clinical indifference will be used: 1) predicted CM = ± 3 hours based on approximately 2x the absolute mean error of our model predictions, 2) insomnia severity = ± 6 points, and 3) depression = 28.5% of the QIDS-SR16 score.

    Measured: From enrollment to the 8 month point.

Secondary outcomes (1)
  1. Assess facilitators and barriers to engagement and implementation.

    A series of semi-structured interviews will be used for thematic analysis, and a comprehensive roadmap for future app updates based on user feedback. The semi-structured interviews will utilize the interview-guide approach following the CFIR framework selected for this study. Six phases will be followed for thematic analysis: (1) data familiarization, (2) generating initial codes, (3) searching for themes, (4) reviewing themes, (5) defining and naming themes, and (6) producing the report. We will combine deductive and inductive techniques to increase the accuracy of thematic analyses.

    Measured: Immediately following completion of 8-month treatment period.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Feb 2025
  2. Study start23 Oct 2023
  3. Primary completionJun 2027 (estimated)
  4. Study completionJun 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06809335
Sponsor's protocol ID
16061
Acronym
SAIL
Status last verified
Feb 2026
First submitted
23 Jan 2025
Last updated
2 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Personalized circadian mHealth in people with Shift Work Sleep Disorder, run by Henry Ford Health System at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 2 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Philip Cheng, PhD (248-344-7361, pcheng1@hfhs.org), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Establish the effect of SHIFT on stakeholder-centered outcomes. (time frame: From enrollment to the 8 month point.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in